Skip to Content

Tag: Arecor


Also Noted

Arecor, Sequel partner to advance diabetes treatment through clinical trials and beyond 

September 29, 2025HME News Staff

CAMBRIDGE, U.K. - Arecor Therapeutics, a biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, has signed a co-development agreement with Sequel Med Tech, a company that is developing insulin delivery technologies. Part of the agreement:  Combining Arecor’s AT278 (500U/ml) with Sequel’s twiist automated insulin deliver (AID) system powered by Tidepool; and  Implementing a royalty financing agreement with Ligand...

Arecor, Clinical Trial, Diabetes, Sequel Med Tech


Read Full Articlered right arrow icon